Ricardo V García-Mayor1, Francisco J García-Soidán2. 1. South Galician Biomedical Foundation, University Hospital of Vigo, P.O. Box 1691, Vigo 36201, Spain. Electronic address: ricardo.garcia.mayor@sergas.es. 2. Porriño Health Care Centre, Pontevedra, Spain.
Abstract
BACKGROUND: Relationship between type 1 diabetes and Eating disorders is well-known, less information exists on the relationship between type 2 diabetes (T2DM) people and eating disorders. AIM: Review information on the prevalence and impact of type 2 diabetes and eating disorders comorbidity. METHODS: Search in Medline and PubMed relevant articles on the aforementioned co-morbidity. Review includes articles on epidemiological, clinical and therapeutics aspects. CONCLUSIONS: Disordered eating behaviours may affect around 40% of T2DM people, being the predominant clinical forms: Eating Disorders Non otherwise specified (EDNOS), Night Eating Syndrome (NES) and Binge Eating Disorder (BED), however, population-based estimates of T2DM and ED comorbidity are mandatory to determine the prevalence of ED in T2DM people. The association between both entities has a consequence which is an impairment of metabolic control, associated to increase risk of vascular complications and difficult body weight loss, basis of T2DM treatment.
BACKGROUND: Relationship between type 1 diabetes and Eating disorders is well-known, less information exists on the relationship between type 2 diabetes (T2DM) people and eating disorders. AIM: Review information on the prevalence and impact of type 2 diabetes and eating disorders comorbidity. METHODS: Search in Medline and PubMed relevant articles on the aforementioned co-morbidity. Review includes articles on epidemiological, clinical and therapeutics aspects. CONCLUSIONS:Disordered eating behaviours may affect around 40% of T2DM people, being the predominant clinical forms: Eating Disorders Non otherwise specified (EDNOS), Night Eating Syndrome (NES) and Binge Eating Disorder (BED), however, population-based estimates of T2DM and ED comorbidity are mandatory to determine the prevalence of ED in T2DM people. The association between both entities has a consequence which is an impairment of metabolic control, associated to increase risk of vascular complications and difficult body weight loss, basis of T2DM treatment.
Authors: Angelique F Ralph; Leah Brennan; Sue Byrne; Belinda Caldwell; Jo Farmer; Laura M Hart; Gabriella A Heruc; Sarah Maguire; Milan K Piya; Julia Quin; Sarah K Trobe; Andrew Wallis; A J Williams-Tchen; Phillipa Hay Journal: J Eat Disord Date: 2022-08-18
Authors: Danilo Dias Santana; Deborah Mitchison; David Gonzalez-Chica; Stephen Touyz; Nigel Stocks; Jose Carlos Appolinario; Gloria Valeria da Veiga; Phillipa Hay Journal: J Eat Disord Date: 2019-11-01
Authors: Maria G Grammatikopoulou; Konstantinos Gkiouras; Georgia Polychronidou; Chrysi Kaparounaki; Kalliopi K Gkouskou; Faidon Magkos; Lorenzo Maria Donini; Aristides G Eliopoulos; Dimitrios G Goulis Journal: Nutrients Date: 2021-10-27 Impact factor: 5.717
Authors: Géssica Damares Garcia; Daniele Alcalá Pompeo; Letícia Palota Eid; Cláudia Bernardi Cesarino; Maria Helena Pinto; Laryssa Wilson Paiva Gonçalves Journal: Rev Lat Am Enfermagem Date: 2018-09-03